Showing results (1071-1080 of 1,147) with videos related to
Sort By:
Pageof 115
Journal of Hepatocellular Carcinoma|March 11, 2024
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular CarcinomaShadi Chamseddine, Michael LaPelusa, Lianchun Xiao, et al.Journal of Hepatocellular Carcinoma|September 30, 2024
The Enhanced Role of Eosinophils in Radiomics-Based Diagnosis of Microvascular Invasion and Its Association with the Immune Microenvironment in Hepatocellular CarcinomaDong Liu, Jianmin Wu, Han Wang, et al.Journal of Hepatocellular Carcinoma|September 23, 2024
ZDHHC20 Activates AKT Signaling Pathway to Promote Cell Proliferation in Hepatocellular CarcinomaXiaoju Huang, Mengmeng Wang, Dan Zhang, et al.Journal of Hepatocellular Carcinoma|September 12, 2024
Differences in Prediagnostic Serum Metabolomic and Lipidomic Profiles Between Cirrhosis Patients with and without Incident Hepatocellular CarcinomaHannah Powell, Cristian Coarfa, Elisa Ruiz-Echartea, et al.Journal of Hepatocellular Carcinoma|March 4, 2024
Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective StudyHongjie Cai, Song Chen, Zhiqiang Wu, et al.Journal of Hepatocellular Carcinoma|February 26, 2024
Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?Vera Himmelsbach, Christine Koch, Jörg Trojan, et al.Journal of Hepatocellular Carcinoma|February 22, 2024
Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi ArabiaAshwaq Alolyan, Kanan Alshammari, Mohammad Arabi, et al.Journal of Hepatocellular Carcinoma|November 15, 2023
Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and CamrelizumabYongqiang Xiao, Guoqing Zhu, Jin Xie, et al.Journal of Hepatocellular Carcinoma|October 26, 2023
Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaTeng Long, Zhoutian Yang, Huilan Zeng, et al.Journal of Hepatocellular Carcinoma|October 30, 2023
The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint InhibitorsHsiao-Mei Hsu, Hsin-I Tsai, Wei-Chen Lee, et al.Pageof 115